Xiaoxin Meng
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Renal cell carcinoma treatment
- Renal and Vascular Pathologies
Papers in
-
- Renal cell carcinoma treatment 7
- Prostate Cancer Diagnosis and Treatment 6
- Ferroptosis and cancer prognosis 2
-
- Cell death mechanisms and regulation 3
- Co-authors
- Changjun Yin (31 shared papers)Xiaobing Ju (31 shared papers)Chao Qin (30 shared papers)Pengfei Shao (27 shared papers)Qiang Cao (20 shared papers)Pu Li (25 shared papers)Qiang Lv (8 shared papers)Jie Li (2 shared papers)
- Journals
- PLoS ONE (6 papers)Urology (3 papers)European Urology (3 papers)American Journal of Men s Health (2 papers)Molecular Carcinogenesis (2 papers)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Xiaoxin Meng
43 papers receiving 997 citations
Peers
Comparison fields: 5 of 79
- Cancer Research 283
- Pulmonary and Respiratory Medicine 338
- Urology 51
- Molecular Biology 425
- Surgery 99
Countries citing papers authored by Xiaoxin Meng
This map shows the geographic impact of Xiaoxin Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoxin Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoxin Meng more than expected).
Fields of papers citing papers by Xiaoxin Meng
This network shows the impact of papers produced by Xiaoxin Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoxin Meng. The network helps show where Xiaoxin Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoxin Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 138 | |
| 2 | 2012 | 91 | |
| 3 | 2013 | 70 | |
| 4 | 2015 | 60 | |
| 5 | 2013 | 54 | |
| 6 | 2013 | 51 | |
| 7 | 2012 | 48 | |
| 8 | 2012 | 45 | |
| 9 | 2014 | 43 | |
| 10 | 2015 | 29 | |
| 11 | 2010 | 27 | |
| 12 | 2012 | 26 | |
| 13 | 2013 | 26 | |
| 14 | 2014 | 26 | |
| 15 | 2011 | 22 | |
| 16 | 2013 | 22 | |
| 17 | 2015 | 19 | |
| 18 | 2011 | 18 | |
| 19 | 2014 | 18 | |
| 20 | 2010 | 15 |
About Xiaoxin Meng
Xiaoxin Meng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Surgery and Urology, having authored 50 papers that have together received 1.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (7 papers), Urinary Bladder and Prostate Research (6 papers), Prostate Cancer Diagnosis and Treatment (6 papers), MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (4 papers), Cell death mechanisms and regulation (3 papers), Bladder and Urothelial Cancer Treatments (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (283 citations), Pulmonary and Respiratory Medicine (338 citations), Urology (51 citations), Molecular Biology (425 citations) and Surgery (99 citations). Xiaoxin Meng has collaborated with scholars based in China and South Korea. Frequent co-authors include Changjun Yin, Xiaobing Ju, Chao Qin, Pengfei Shao, Qiang Cao, Pu Li, Qiang Lv, Jie Li, Meilin Wang and Hongzhou Cai. Their work appears in journals such as PLoS ONE, Urology, European Urology, American Journal of Men s Health and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.